| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8445163 | European Journal of Cancer | 2013 | 7 Pages |
Abstract
CEP-18770 showed a favourable safety profile with lack of neurotoxicity and linear plasma PK. The definition of the optimal biological dose and schedule of treatment is actively pursued because of the high incidence of skin toxicity of the twice a week schedule.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Elisa Gallerani, Massimo Zucchetti, Dario Brunelli, Elena Marangon, Cristina Noberasco, Dagmar Hess, Angelo Delmonte, Giovanni Martinelli, Steffen Böhm, Christopher Driessen, Filippo De Braud, Silvia Marsoni, Roberta Cereda, Federica Sala,